News | News By Subject | News by Disease News By Date | Search News

Anti-infective News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Cowen: Achaogen (AKAO)’s New Antibiotic Could Be Key to Solving Types of Drug Resistance     11/17/2014
Advancis Pharmaceutical Corporation (AVNC) Announces Positive Results For Amoxicillin PULSYS Phase III Trial; All Trial Endpoints Achieved     8/10/2006
TriMed Research, Inc. Secures EUR 5 Million In Series A Funding; Testing of New Anti-Infective Compounds Moves Forward     6/21/2005
Frank Armstrong, M.D., Named Chief Executive Officer Of Bioaccelerate Inc.     4/18/2005
Helix BioMedix, Inc. (HXBM) Announces Anti-Infective Collaboration With Smith & Nephew (SNN)     1/21/2005
Merck & Co. (MRK) Executes Exclusive Patent License And Collaborative Research And Development Agreement With Kyorin Pharmaceutical Co., Ltd.; Research Collaboration To Focus On Antibiotics     8/19/2004

News from Around the Web
No News Posted on that date

Press Releases
Optimer Pharmaceuticals, Inc. Receives Polymorph Patent for Lead Product Candidate OPT-80     5/27/2008
Dutch Biopharmaceutical Company AM-Pharma Holding BV Strengthens Intellectual Property Position For Lactoferrin Derived Antimicrobial Peptide hLF1-11     8/10/2006
KV Pharmaceutical Company (KVA) Announces Approvals For Its Gynazole-1(R) In 15 Countries     8/17/2005
Cornerstone BioPharma, Inc. And Lupin Ltd. (LUPN.BO) Announce A Development And Licensing Agreement     5/9/2005
Sanofi-Aventis (Canada) Release: Ketek(R) Offers The First Five-Day Antibiotic Treatment For Acute Sinusitis     4/25/2005
Cornerstone BioPharma, Inc. Expands Nationwide Sales Force     4/25/2005
V.I. Technologies, Inc. (VITEX) (VITXD) And Panacos Pharmaceuticals Inc. (PANC) Shareholders Approve Merger     3/10/2005
V.I. Technologies, Inc. (VITEX) (VITX) To Present At The SunTrust Robinson Humphrey Therapeutics Conference     2/23/2005
Cubist Pharmaceuticals, Inc. (CBST) Announces Completion Of Treatment Phase For All Patients In The Cubicin Endocarditis/Bacteremia Study; DMC Completes The Fifth Safety Review     2/22/2005
Vitex Receives Extension From NASDAQ Relating To Minimum Stockholders' Equity Listing Requirement     2/22/2005
GMP Companies, Inc. Announces Results Of Preliminary In Vitro Testing Of Novel Topical Anti-Infective Technology     2/8/2005
Advancis Pharmaceutical Corporation To Begin Pediatric Amoxicillin PULSYS Phase III Trial     12/17/2004
Advancis Pharmaceutical Corporation Modifies Amoxicillin PULSYS Agreement     12/15/2004
Study Of Advancis Pharmaceutical Corporation's Pulsatile Dosing Published In Journal Of Antimicrobial Chemotherapy     12/13/2004
Pediatric Trials Increasing In Response To New Regulations; Represent A Growing Area Of Focus For Kendle International (KNDL)     12/13/2004